U.S. Physical Therapy’s (USPH) “Market Perform” Rating Reiterated at William Blair

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “market perform” rating reiterated by stock analysts at William Blair in a research report issued on Thursday,RTT News reports.

A number of other equities research analysts have also recently issued reports on the company. Barrington Research restated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a report on Thursday, November 21st. JPMorgan Chase & Co. boosted their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. JMP Securities assumed coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 price objective on the stock. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $100.00 to $115.00 in a report on Monday, December 16th. Finally, Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and an average price target of $114.00.

U.S. Physical Therapy Stock Down 5.4 %

NYSE:USPH traded down $4.77 during trading hours on Thursday, reaching $82.95. 35,658 shares of the stock were exchanged, compared to its average volume of 90,476. The stock has a market cap of $1.25 billion, a PE ratio of 86.72, a PEG ratio of 3.54 and a beta of 1.48. U.S. Physical Therapy has a twelve month low of $76.18 and a twelve month high of $113.63. The firm has a 50 day moving average of $88.59 and a 200 day moving average of $87.70. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The company had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. On average, equities analysts expect that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

Insider Buying and Selling

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the transaction, the chief financial officer now owns 20,469 shares in the company, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

Several large investors have recently modified their holdings of the company. CBIZ Investment Advisory Services LLC lifted its position in shares of U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after purchasing an additional 122 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of U.S. Physical Therapy during the 4th quarter worth approximately $39,000. Venturi Wealth Management LLC boosted its stake in shares of U.S. Physical Therapy by 3,200.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock worth $64,000 after buying an additional 704 shares during the last quarter. KBC Group NV grew its holdings in shares of U.S. Physical Therapy by 68.6% in the third quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after acquiring an additional 315 shares in the last quarter. Finally, Lazard Asset Management LLC bought a new stake in U.S. Physical Therapy during the fourth quarter worth $84,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.